Stem Cell–Derived Islets Continue to Show Benefit in T1D
ORLANDO, Fla — Stem cell–derived beta-cell replacement therapy continues to show benefit in people with type 1 diabetes at a high risk for severe hypoglycemia. Of a total 17 patients who received a full dose of Vertex Pharmaceuticals, Inc.'s …